![Dr. Evon Dellon-weekly-dupilumab-results](https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/unc-study-of-elimination-diet-for-eosinophilic-esophagitis-among-top-10-downloaded-in-apt-journal-image3-240x300.jpeg)
Evon S. Dellon, MD, MPH, professor in the department of medicine’s division of gastroenterology and hepatology, discussed the Phase 3 LIBERTY-EoE-TREET study for Dupixent (Dupilumab). The results were presented at the American Academy of Allergy, Asthma & Immunology’s Annual Meeting.